Address: SymPhar Sp. z.o.o.
ul. Włoska 1
Warsaw 00-777
Poland ,Poland
Tel: (022) 822 93 06
We are a young Polish pharmaceutical company with Australian roots. We integrate the timeless values of both cultures for the benefit of patients and customers.
The original inhabitants of Australia believed that the kangaroo was a symbol of physical and spiritual strength and a guide who protected them and showed them the right way. We have used this timeless icon as our logo to demonstrate our strength, speed and determination, but at the same time as a symbol of our commitment to the right way, both in a strategic and ethical context.
SymPhar shows the way.
SymPhar is a multidimensional company:
We cooperate with Polish and international companies in bringing the benefits of their products to Polish health care professionals, patients and consumers.
We assist smaller European companies with products filling valuable therapeutic niches in making their products available in Poland.
We supply our own products to the Polish market. These are products identical in composition, efficacy and safety to well-known “Big Pharma” products but at a much reduced cost. We don’t invest huge amounts in promotion, therefore we can provide these essential medical products at a price which suits the Polish pocket.
Some of the biggest stories coming out of the Central and Eastern European (CEE) region’s pharma industry, including the European Bank’s EUR 25 million investment in Pelion Group; the amendments…
With a geostrategic location and easy access to both Western Europe and the rest of the emerging Central and Eastern Europe (CEE) region, Poland represents the sixth largest pharma market…
Poland’s largest pharmaceutical company and leading generics manufacturer, Polpharma, is looking to expand its presence outside of the country’s borders. With a recent acquisition bid for former Sanofi European generics…
Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma’s bid for Zentiva, Richter’s acquisition of OC Distributors and MDD approval…
Some of the top stories emanating from Poland’s pharma industry, including Polish biotech Ryvu Therapeutics’ exclusive deal with Exelixis, the partnership between Polpharma and startup Pikralida on a promising epilepsy…
Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Poland’s most promising biotech start-ups, an interview with Zentiva CEO Nick Haggar,…
Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all industries. Here, we profile the top five pharma-related companies featured in the 2019 rankings.…
Reinier Schlatmann, Philips CEO in Central and Eastern Europe, talks about the strategic significance of Poland for the company and how the implementation of Philips’ strategy and its focus on…
Ewa Sek, general manager at ResMed Poland, explains the crucial role of ResMed in raising awareness on sleep apnea, COPD and other respiratory-related conditions in Poland and highlights the important…
Jan Kruk of Polish pharmaceutical logistics and distribution specialist, Cefarm, discusses the organization’s secrets of success, as well as the broader logistics and distribution landscape in Poland. As the president…
Arjo, formerly Arjo Huntleigh, has undergone a rebrand and established its first formal office in Poland in 2017. Konrad Pianko, president of the CEE region which includes over 22 countries,…
Dariusz Adamusiński, general manager of A&D Pharma’s Polish operations has a busy year ahead. A new warehouse in Poland, partnerships across the pharmaceutical spectrum coupled with new regulations are all…
See our Cookie Privacy Policy Here
